Recurrence rate of atrial flutter after initial presentation in patients on drug treatment - 28/08/11
Doi : 10.1016/j.amjcard.2003.06.013
Anvar Babaev, MD, PhD a, Valentin Suma, MD a, Cristina Tita, MD a, Jonathan S. Steinberg, MD a, ⁎ 
a Arrhythmia Service and Division of Cardiology, St. Luke's-Roosevelt Hospital Center, and Columbia University College of Physicians & Surgeons, New York, New York, USA
*Dr. Steinberg's address is: Division of Cardiology, St. Luke's-Roosevelt Hospital Center, 1111 Amsterdam Avenue, New York, New York 10025, USA.
Abstract |
Atrial flutter (AFl) recurrence after initial in-patient presentation, cardioversion, and drug treatment is almost universal, often leading to rehospitalization and risk of serious clinical consequences. Radiofrequency ablation of AFl, which has an excellent safety record, should be evaluated as a first-line approach for most patients with AFl.
Le texte complet de cet article est disponible en PDF.© 2003
Excerpta Medica Inc. Tous droits réservés.
Vol 92 - N° 9
P. 1122-1124 - novembre 2003 Retour au numéro
Article précédent
- Atropine-facilitated electrical cardioversion of persistent atrial fibrillation
- Edo Kaluski, Alex Blatt, Marina Leitman, Ricardo Krakover, Zvi Vered, Gad Cotter
- Brain natriuretic peptide is elevated in outpatients with atrial fibrillation
- Helme Silvet, Yinong Young-Xu, Diana Walleigh, Shmuel Ravid
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?